[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 30, 1960

EFFECTS OF LARGE INFREQUENT DOSES OF A-METHOPTERIN ON ACUTE LEUKEMIA IN CHILDREN

Author Affiliations

Oklahoma City

From the Oklahoma Medical Research Institute.

JAMA. 1960;172(5):451-453. doi:10.1001/jama.1960.63020050004013
Abstract

The importance of dosage in the treatment of mouse leukemia with a-methopterin (Methotrexate) has been demonstrated by Goldin and associates.1 They found in the treatment of leukemia L 1210 that a schedule of large, infrequent doses of a-methopterin was, with regard to survival time, therapeutically superior to single maximum doses or to small, consecutive daily doses, if treatment was begun soon after tumor implantation. The optimum interval of four days between consecutive doses was subsequently shown to be closely related to the time required for recovery of the mouse from the effects of the drug.2 The enhanced therapeutic effectiveness of this intermittent regimen suggested that the host recovered faster than the tumor, so that the tumor was damaged selectively by subsequent doses of the drug.

The therapeutic advantage of this dosage regimen was so obvious that its clinical application was undertaken. Studies in man led to the selection

First Page Preview View Large
First page PDF preview
First page PDF preview
×